Management of MDD with a Focus on PGx | Part 3: The “Other Antidepressants”
Learn how less commonly prescribed antidepressants may impact treatment decisions for major depressive disorder.
Management of MDD with a Focus on PGx | Part 2: Pharmacokinetic Considerations of First-Line Antidepressants
Learn how pharmacokinetic gene variations may impact first-line pharmacologic treatments for major depressive disorder
Management of MDD with a Focus on PGx | Part 1: Pharmacodynamic Considerations of First-Line Antidepressants
Learn how pharmacodynamic gene variations may impact first-line pharmacologic treatments for major depressive disorder.
Medicare Provides Coverage of the Genomind PGx Test
Major Advancement in Support for Mental Health Patients as Medicare Provides Coverage of the Genomind Professional PGx Express Test and the VA Extends FSS Contract to Help Soldiers and Veterans.